Lung Cancers Completed Phase 1 Trials for Sargramostim (DB00020)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003002HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung CancerTreatment
NCT00005023Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV CancerTreatment
NCT00398138Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or MesotheliomaTreatment
NCT00005630Vaccine Therapy and Sargramostim in Treating Patients With Non-small Cell Lung CancerTreatment